<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD02120000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P04637</UniProt_ID>
  <Seq_Length>393</Seq_Length>
  <Molecule_Weight>43653</Molecule_Weight>
  <KEGG_ID>hsa:7157</KEGG_ID>
  <Orthology_ID>K04451</Orthology_ID>
  <EBI_ID>EBI-366083</EBI_ID>
  <Function_Summary>Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis.</Function_Summary>
  <Pfam_ID>PF00870:P53@@PF08563:P53_TAD@@PF07710:P53_tetramer</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>16</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>P53 transformation suppressor</Alias>
      <Alias>Tumor protein p53</Alias>
      <Alias>P53 tumor suppressor</Alias>
      <Alias>Transformation-related protein 53</Alias>
      <Alias>Phosphoprotein p53</Alias>
      <Alias>Antigen NY-CO-13</Alias>
      <Alias>P53 antigen</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with copper (Cu) ions.</Detail>
      <Keyword>Copper ion binding</Keyword>
      <Ontology_ID>GO:0005507</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Protein that positively regulates either the transcription of one or more genes, or the translation of mRNA.</Detail>
      <Keyword>Activator</Keyword>
      <Ontology_ID>KW-0010</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.</Detail>
      <Keyword>Chaperone binding</Keyword>
      <Ontology_ID>GO:0051087</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.</Detail>
      <Keyword>Protein heterodimerization activity</Keyword>
      <Ontology_ID>GO:0046982</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any transcription regulator activity that prevents or downregulates transcription.</Detail>
      <Keyword>Transcription repressor activity</Keyword>
      <Ontology_ID>GO:0016564</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protease or peptidase.</Detail>
      <Keyword>Protease binding</Keyword>
      <Ontology_ID>GO:0002020</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a DNA region that regulates the transcription of a region of DNA, which may be a gene, cistron, or operon. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors.</Detail>
      <Keyword>Transcription regulatory region DNA binding</Keyword>
      <Ontology_ID>GO:0044212</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Any molecular function by which a gene product interacts selectively with DNA (deoxyribonucleic acid).</Detail>
      <Keyword>DNA binding</Keyword>
      <Ontology_ID>GO:0003677</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with chromatin, the network of fibers of DNA and protein that make up the chromosomes of the eukaryotic nucleus during interphase.</Detail>
      <Keyword>Chromatin binding</Keyword>
      <Ontology_ID>GO:0003682</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Facilitates the base-pairing of complementary single-stranded DNA.</Detail>
      <Keyword>DNA strand annealing activity</Keyword>
      <Ontology_ID>GO:0000739</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with damaged DNA.</Detail>
      <Keyword>Damaged DNA binding</Keyword>
      <Ontology_ID>GO:0003684</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.</Detail>
      <Keyword>Protein phosphatase 2A binding</Keyword>
      <Ontology_ID>GO:0051721</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.</Detail>
      <Keyword>Ubiquitin protein ligase binding</Keyword>
      <Ontology_ID>GO:0031625</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an RNA polymerase II transcription factor, any protein required to initiate or regulate transcription by RNA polymerase II.</Detail>
      <Keyword>RNA polymerase II transcription factor binding</Keyword>
      <Ontology_ID>GO:0001085</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with one of the p53 family of proteins.</Detail>
      <Keyword>P53 binding</Keyword>
      <Ontology_ID>GO:0002039</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the enzyme histone acetyltransferase.</Detail>
      <Keyword>Histone acetyltransferase binding</Keyword>
      <Ontology_ID>GO:0035035</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein or proteins.</Detail>
      <Keyword>Identical protein binding</Keyword>
      <Ontology_ID>GO:0042802</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.</Detail>
      <Keyword>Protein N-terminus binding</Keyword>
      <Ontology_ID>GO:0047485</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.</Detail>
      <Keyword>Protein kinase binding</Keyword>
      <Ontology_ID>GO:0019901</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>84</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>186</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>311</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>347</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>295</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Gly</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>326</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>287</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>307</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>364</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>298</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>224</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>107</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>109</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>298</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>196</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>316</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>209</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>319</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Val</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>203</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>77</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>108</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>318</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>88</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>298</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>220</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>186</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>212</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Gly</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>60</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>313</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>106</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>266</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>328</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>266</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>209</Position>
      <Original>Arg</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>325</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Trp</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>202</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>211</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>363</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>128</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>186</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>211</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>232</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>302</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>330</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>101</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>138</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>199</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>211</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>232</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>188</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>267</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>100</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>35</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>330</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>89</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>218</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>111</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>328</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>85</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>358</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>317</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>80</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Phe</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>91</Position>
      <Original>Trp</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>279</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>92</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>99</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>149</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Leu</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>267</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>263</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Ser</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>197</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>287</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>116</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>123</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>102</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>329</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>263</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>310</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>237</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>322</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>338</Position>
      <Original>Phe</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>237</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>182</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>370</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>115</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>272</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>24</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>197</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>256</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>196</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>116</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>302</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>330</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>15</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>211</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>83</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>92</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>52</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>295</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>81</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>288</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>188</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>212</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Phe</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>321</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>94</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>263</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>327</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>290</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>358</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>309</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>107</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>31</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>300</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>256</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>313</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>325</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Cys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>284</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>364</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>305</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Trp</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>201</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>44</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>221</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Trp</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>335</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>119</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>101</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>354</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>344</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>232</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>49</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>184</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>138</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>119</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Arg</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>42</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>334</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Phe</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>288</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Asn</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>213</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>288</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>317</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>316</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>43</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>88</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>203</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>317</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>263</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Pro</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>325</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>180</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>180</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Phe</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>63</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>206</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>85</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>343</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>58</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>111</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>260</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>304</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>341</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>267</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>199</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>287</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>317</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>319</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>335</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>202</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>352</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>218</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>366</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>266</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>10</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>47</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>212</Position>
      <Original>Phe</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>344</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>337</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>137</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>86</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>197</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>224</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>308</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>356</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>335</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>349</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>94</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>291</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>293</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>298</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>80</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>295</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>206</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>138</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>321</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>180</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>48</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Gly</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>284</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>76</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>104</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>137</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>189</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>327</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>97</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>201</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>220</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>127</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>111</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>290</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>299</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>56</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>120</Position>
      <Original>Lys</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Trp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>226</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>360</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>312</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>78</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>288</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>203</Position>
      <Original>Val</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>262</Position>
      <Original>Gly</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>339</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>220</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>339</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>128</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>106</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>108</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>61</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>45</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>306</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>189</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>272</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>299</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Leu</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>279</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>293</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>7</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>153</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>Thr</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>82</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>360</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>288</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>120</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>303</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>320</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>260</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>238</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>184</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>224</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>221</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>199</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>46</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>303</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>122</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>111</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>213</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>221</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>329</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>279</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>211</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>87</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>256</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>75</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>192</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>196</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>297</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Phe</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>202</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>311</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>260</Position>
      <Original>Ser</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>306</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>232</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>392</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>224</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>184</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>237</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>138</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>267</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Trp</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>229</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>213</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>266</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>272</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>150</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>328</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>311</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>307</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>49</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>189</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>182</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>262</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>59</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>84</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>304</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>98</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>146</Position>
      <Original>Trp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>11</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>136</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>180</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>90</Position>
      <Original>Ser</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>308</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>65</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>213</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>16</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>305</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Pro</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>218</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>237</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>120</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>37</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>209</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>160</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Met</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>312</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>365</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>298</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>324</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>279</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>221</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>331</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>314</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>300</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>139</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>83</Position>
      <Original>Ala</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>54</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>202</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>121</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>269</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>196</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>220</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>220</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>167</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>385</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>302</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>186</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>62</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>129</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>125</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>8</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>66</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>276</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>204</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>192</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>332</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>175</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>218</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>133</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>285</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>304</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>309</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>92</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>315</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>310</Position>
      <Original>Asn</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>128</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>337</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>290</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>283</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>262</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>212</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>151</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>53</Position>
      <Original>Trp</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>346</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>99</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>112</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>348</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>168</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>315</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>203</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>143</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>193</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>154</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>261</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>230</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Met</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>260</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>71</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>172</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>295</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>347</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>293</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>323</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>389</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>72</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>134</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>264</Position>
      <Original>Leu</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>304</Position>
      <Original>Thr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Ser</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>169</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>254</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>178</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>104</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>282</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>44</Position>
      <Original>Met</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>356</Position>
      <Original>Gly</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>305</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>228</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>287</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Val</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>142</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>203</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>192</Position>
      <Original>Gln</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>152</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Phe</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>163</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>334</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>210</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>354</Position>
      <Original>Gln</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>353</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>246</Position>
      <Original>Met</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>74</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>322</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>247</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>76</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Tyr</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>189</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>89</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>262</Position>
      <Original>Gly</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>220</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>196</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>376</Position>
      <Original>Ser</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Asn</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>109</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>277</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Arg</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>47</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>305</Position>
      <Original>Lys</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>305</Position>
      <Original>Lys</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>149</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>93</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>218</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>272</Position>
      <Original>Val</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>239</Position>
      <Original>Asn</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>124</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Ser</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>265</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>182</Position>
      <Original>Cys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>275</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>180</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>199</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>337</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>186</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>300</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>270</Position>
      <Original>Phe</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>73</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>63</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>95</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>140</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>237</Position>
      <Original>Met</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>149</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>187</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>His</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>262</Position>
      <Original>Gly</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>181</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>244</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>354</Position>
      <Original>Gln</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>240</Position>
      <Original>Ser</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>184</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>317</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>54</Position>
      <Original>Phe</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>183</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>159</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>379</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>278</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>284</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>271</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>258</Position>
      <Original>Glu</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>376</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>116</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>253</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>299</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>209</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>232</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>6</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>137</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>201</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>109</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>176</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>189</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>364</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>132</Position>
      <Original>Lys</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>263</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>138</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>245</Position>
      <Original>Gly</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>281</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>215</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>208</Position>
      <Original>Asp</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>292</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>34</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>202</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>221</Position>
      <Original>Glu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>307</Position>
      <Original>Ala</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>107</Position>
      <Original>Tyr</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>147</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>338</Position>
      <Original>Phe</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>250</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>49</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>135</Position>
      <Original>Cys</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>294</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>171</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Thr</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>296</Position>
      <Original>His</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>323</Position>
      <Original>Leu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>323</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>186</Position>
      <Original>Asp</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>164</Position>
      <Original>Lys</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>44</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>303</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asp</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>319</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Ala</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>33</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>315</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>105</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>60</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Arg</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>248</Position>
      <Original>Arg</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Tyr</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>241</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>233</Position>
      <Original>His</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>130</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>148</Position>
      <Original>Asp</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>158</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Ser</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>156</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>123</Position>
      <Original>Thr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>287</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>137</Position>
      <Original>Leu</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>284</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>249</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>324</Position>
      <Original>Asp</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>185</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>117</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>242</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>243</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>191</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>118</Position>
      <Original>Thr</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>272</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>214</Position>
      <Original>His</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>28</Position>
      <Original>Glu</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>348</Position>
      <Original>Leu</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>113</Position>
      <Original>Phe</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>70</Position>
      <Original>Ala</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>216</Position>
      <Original>Val</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>365</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>236</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>311</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>198</Position>
      <Original>Glu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>237</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>260</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>192</Position>
      <Original>Gln</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>286</Position>
      <Original>Glu</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>128</Position>
      <Original>Pro</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>144</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>190</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>155</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>120</Position>
      <Original>Lys</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>342</Position>
      <Original>Arg</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>300</Position>
      <Original>Pro</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>36</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>256</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>260</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>225</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asp</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>His</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>299</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Ile</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>161</Position>
      <Original>Ala</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>189</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>180</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>323</Position>
      <Original>Leu</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>303</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>183</Position>
      <Original>Ser</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Thr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>232</Position>
      <Original>Ile</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>145</Position>
      <Original>Leu</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>223</Position>
      <Original>Pro</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>197</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>280</Position>
      <Original>Arg</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>252</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>174</Position>
      <Original>Arg</Original>
      <Variation>Trp</Variation>
    </Muntion>
    <Muntion>
      <Position>323</Position>
      <Original>Leu</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>273</Position>
      <Original>Arg</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>207</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>79</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>313</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>205</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>302</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>337</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>141</Position>
      <Original>Cys</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>301</Position>
      <Original>Pro</Original>
      <Variation>Gln</Variation>
    </Muntion>
    <Muntion>
      <Position>235</Position>
      <Original>Asn</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>173</Position>
      <Original>Val</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Leu</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>274</Position>
      <Original>Val</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>324</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>170</Position>
      <Original>Thr</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>162</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>69</Position>
      <Original>Ala</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>11</Position>
      <Original>Glu</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>255</Position>
      <Original>Ile</Original>
      <Variation>Met</Variation>
    </Muntion>
    <Muntion>
      <Position>68</Position>
      <Original>Glu</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>165</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>313</Position>
      <Original>Ser</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>293</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>212</Position>
      <Original>Phe</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>17</Position>
      <Original>Glu</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>192</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>131</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>110</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>267</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>219</Position>
      <Original>Pro</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>217</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>195</Position>
      <Original>Ile</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>177</Position>
      <Original>Pro</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>126</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>227</Position>
      <Original>Ser</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>289</Position>
      <Original>Leu</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>5</Position>
      <Original>Gln</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>184</Position>
      <Original>Asp</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>157</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>213</Position>
      <Original>Arg</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>202</Position>
      <Original>Arg</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>251</Position>
      <Original>Ile</Original>
      <Variation>Phe</Variation>
    </Muntion>
    <Muntion>
      <Position>259</Position>
      <Original>Asp</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Pro</Original>
      <Variation>Thr</Variation>
    </Muntion>
    <Muntion>
      <Position>200</Position>
      <Original>Asn</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>234</Position>
      <Original>Tyr</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>194</Position>
      <Original>Leu</Original>
      <Variation>His</Variation>
    </Muntion>
    <Muntion>
      <Position>60</Position>
      <Original>Pro</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>96</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptosis.</Detail>
      <Keyword>Positive regulation of neuron apoptosis</Keyword>
      <Ontology_ID>GO:0043525</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.</Detail>
      <Keyword>Cellular response to drug</Keyword>
      <Ontology_ID>GO:0035690</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits.</Detail>
      <Keyword>Protein tetramerization</Keyword>
      <Ontology_ID>GO:0051262</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.</Detail>
      <Keyword>Positive regulation of reactive oxygen species metabolic process</Keyword>
      <Ontology_ID>GO:2000379</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Regulation of transcription</Keyword>
      <Ontology_ID>GO:0045449</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of protein oligomerization.</Detail>
      <Keyword>Positive regulation of protein oligomerization</Keyword>
      <Ontology_ID>GO:0032461</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated by the accumulation of normal or misfolded proteins in the endoplasmic reticulum and leading to activation of transcription by NF-kappaB.</Detail>
      <Keyword>ER overload response</Keyword>
      <Ontology_ID>GO:0006983</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, resulting in the induction of the transcription of p21 (also known as WAF1, CIP1 and SDI1) or any equivalent protein, in response to the detection of DNA damage.</Detail>
      <Keyword>DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator</Keyword>
      <Ontology_ID>GO:0006978</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the stopping or reduction in rate of the cell cycle.</Detail>
      <Keyword>DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest</Keyword>
      <Ontology_ID>GO:0006977</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of glucose.</Detail>
      <Keyword>Cellular response to glucose starvation</Keyword>
      <Ontology_ID>GO:0042149</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.</Detail>
      <Keyword>Cellular response to ionizing radiation</Keyword>
      <Ontology_ID>GO:0071479</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>In base excision repair, an altered base is removed by a DNA glycosylase enzyme, followed by excision of the resulting sugar phosphate. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase.</Detail>
      <Keyword>Base-excision repair</Keyword>
      <Ontology_ID>GO:0006284</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of thymocyte death by apoptosis.</Detail>
      <Keyword>Positive regulation of thymocyte apoptosis</Keyword>
      <Ontology_ID>GO:0070245</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The control of viability and duration in the adult phase of the life-cycle.</Detail>
      <Keyword>Determination of adult lifespan</Keyword>
      <Ontology_ID>GO:0008340</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A DNA repair process in which a small region of the strand surrounding the damage is removed from the DNA helix as an oligonucleotide. The small gap left in the DNA helix is filled in by the sequential action of DNA polymerase and DNA ligase. Nucleotide excision repair recognizes a wide range of substrates, including damage caused by UV irradiation (pyrimidine dimers and 6-4 photoproducts) and chemicals (intrastrand cross-links and bulky adducts).</Detail>
      <Keyword>Nucleotide-excision repair</Keyword>
      <Ontology_ID>GO:0006289</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis.</Detail>
      <Keyword>Negative regulation of apoptosis</Keyword>
      <Ontology_ID>GO:0043066</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.</Detail>
      <Keyword>Positive regulation of release of cytochrome c from mitochondria</Keyword>
      <Ontology_ID>GO:0090200</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.</Detail>
      <Keyword>Regulation of mitochondrial membrane permeability</Keyword>
      <Ontology_ID>GO:0046902</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz).</Detail>
      <Keyword>Response to X-ray</Keyword>
      <Ontology_ID>GO:0010165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cascade of processes induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage and resulting in the initiation of apoptosis (programmed cell death).</Detail>
      <Keyword>DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis</Keyword>
      <Ontology_ID>GO:0042771</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the removal of acetyl groups from histones.</Detail>
      <Keyword>Positive regulation of histone deacetylation</Keyword>
      <Ontology_ID>GO:0031065</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.</Detail>
      <Keyword>Positive regulation of peptidyl-tyrosine phosphorylation</Keyword>
      <Ontology_ID>GO:0050731</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops or reduces the activity of a helicase.</Detail>
      <Keyword>Negative regulation of helicase activity</Keyword>
      <Ontology_ID>GO:0051097</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell growth.</Detail>
      <Keyword>Negative regulation of cell growth</Keyword>
      <Ontology_ID>GO:0030308</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of transcription from the RNA polymerase II promoter.</Detail>
      <Keyword>Positive regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0045944</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.</Detail>
      <Keyword>Cellular response to hypoxia</Keyword>
      <Ontology_ID>GO:0071456</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cellular senescence process associated with the dismantling of a cell as a response to oxidative stress, e.g. high levels of reactive oxygen species, such as superoxide anions, hydrogen peroxide, and hydroxyl radicals.</Detail>
      <Keyword>Oxidative stress-induced premature senescence</Keyword>
      <Ontology_ID>GO:0090403</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.</Detail>
      <Keyword>Negative regulation of fibroblast proliferation</Keyword>
      <Ontology_ID>GO:0048147</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular synthesis of either RNA on a template of DNA or DNA on a template of RNA.</Detail>
      <Keyword>Transcription</Keyword>
      <Ontology_ID>GO:0006350</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cellular senescence process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging.</Detail>
      <Keyword>Replicative senescence</Keyword>
      <Ontology_ID>GO:0090399</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.</Detail>
      <Keyword>Cell cycle</Keyword>
      <Ontology_ID>GO:0007049</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.</Detail>
      <Keyword>Response to gamma radiation</Keyword>
      <Ontology_ID>GO:0010332</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which a protein is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell.</Detail>
      <Keyword>Cellular protein localization</Keyword>
      <Ontology_ID>GO:0034613</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state.</Detail>
      <Keyword>Ras protein signal transduction</Keyword>
      <Ontology_ID>GO:0007265</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.</Detail>
      <Keyword>Cellular response to UV</Keyword>
      <Ontology_ID>GO:0034644</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms.</Detail>
      <Keyword>Response to antibiotic</Keyword>
      <Ontology_ID>GO:0046677</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.</Detail>
      <Keyword>Negative regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0000122</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>372</Position>
      <PTM_Type>N6-methyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>37</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>381</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>373</Position>
      <PTM_Type>N6,N6-dimethyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>382</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>99</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>55</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>315</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>382</Position>
      <PTM_Type>N6-methyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>314</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>183</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>33</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>269</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>18</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>9</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>313</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>370</Position>
      <PTM_Type>N6,N6-dimethyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>20</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>46</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>392</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>305</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>373</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>370</Position>
      <PTM_Type>N6-methyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>292</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
    <PTM>
      <Position>284</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>15</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD</Protein_Seq>
    <DNA_Seq>GTCTAGAGCCACCGTCCAGGGAGCAGGTAGCTGCTGGGCTCCGGGGACACTTTGCGTTCGGGCTGGGAGCGTGCTTTCCACGACGGTGACACGCTTCCCTGGATTGGCAGCCAGACTGCCTTCCGGGTCACTGCCATGGAGGAGCCGCAGTCAGATCCTAGCGTCGAGCCCCCTCTGAGTCAGGAAACATTTTCAGACCTATGGAAACTACTTCCTGAAAACAACGTTCTGTCCCCCTTGCCGTCCCAAGCAATGGATGATTTGATGCTGTCCCCGGACGATATTGAACAATGGTTCACTGAAGACCCAGGTCCAGATGAAGCTCCCAGAATGCCAGAGGCTGCTCCCCCCGTGGCCCCTGCACCAGCAGCTCCTACACCGGCGGCCCCTGCACCAGCCCCCTCCTGGCCCCTGTCATCTTCTGTCCCTTCCCAGAAAACCTACCAGGGCAGCTACGGTTTCCGTCTGGGCTTCTTGCATTCTGGGACAGCCAAGTCTGTGACTTGCACGTACTCCCCTGCCCTCAACAAGATGTTTTGCCAACTGGCCAAGACCTGCCCTGTGCAGCTGTGGGTTGATTCCACACCCCCGCCCGGCACCCGCGTCCGCGCCATGGCCATCTACAAGCAGTCACAGCACATGACGGAGGTTGTGAGGCGCTGCCCCCACCATGAGCGCTGCTCAGATAGCGATGGTCTGGCCCCTCCTCAGCATCTTATCCGAGTGGAAGGAAATTTGCGTGTGGAGTATTTGGATGACAGAAACACTTTTCGACATAGTGTGGTGGTGCCCTATGAGCCGCCTGAGGTTGGCTCTGACTGTACCACCATCCACTACAACTACATGTGTAACAGTTCCTGCATGGGCGGCATGAACCGGAGGCCCATCCTCACCATCATCACACTGGAAGACTCCAGTGGTAATCTACTGGGACGGAACAGCTTTGAGGTGCGTGTTTGTGCCTGTCCTGGGAGAGACCGGCGCACAGAGGAAGAGAATCTCCGCAAGAAAGGGGAGCCTCACCACGAGCTGCCCCCAGGGAGCACTAAGCGAGCACTGCCCAACAACACCAGCTCCTCTCCCCAGCCAAAGAAGAAACCACTGGATGGAGAATATTTCACCCTTCAGATCCGTGGGCGTGAGCGCTTCGAGATGTTCCGAGAGCTGAATGAGGCCTTGGAACTCAAGGATGCCCAGGCTGGGAAGGAGCCAGGGGGGAGCAGGGCTCACTCCAGCCACCTGAAGTCCAAAAAGGGTCAGTCTACCTCCCGCCATAAAAAACTCATGTTCAAGACAGAAGGGCCTGACTCAGACTGA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Widely expressed</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>TP53</Gene_Name>
    <Gene_Alias>P53</Gene_Alias>
    <Gene_ID>7157</Gene_ID>
    <Genbank_ACCN>NM_000546</Genbank_ACCN>
    <Protein_ACCN>NP_000537</Protein_ACCN>
    <HGNC_ID>11998</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7157</Gene_URL>
    <UCSC_ID>uc010cni.1</UCSC_ID>
    <EMBL_ID>ENSG00000141510</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q9PST7</Uniprot_ID>
      <Gene_Name>znf585b</Gene_Name>
      <EBI_ID>EBI-1782562</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1782562</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8IWT3</Uniprot_ID>
      <Gene_Name>CUL9</Gene_Name>
      <EBI_ID>EBI-311123</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-311123</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9UER7</Uniprot_ID>
      <Gene_Name>DAXX</Gene_Name>
      <EBI_ID>EBI-77321</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-77321</PPI_EBI_URL>
      <Experiment_Number>11</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P09874</Uniprot_ID>
      <Gene_Name>PARP1</Gene_Name>
      <EBI_ID>EBI-355676</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-355676</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O15151</Uniprot_ID>
      <Gene_Name>MDM4</Gene_Name>
      <EBI_ID>EBI-398437</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-398437</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P04637</Uniprot_ID>
      <Gene_Name>TP53</Gene_Name>
      <EBI_ID>EBI-366083</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-366083</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q06609</Uniprot_ID>
      <Gene_Name>RAD51</Gene_Name>
      <EBI_ID>EBI-297202</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-297202</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9H3D4</Uniprot_ID>
      <Gene_Name>TP63</Gene_Name>
      <EBI_ID>EBI-2337775</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-2337775</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92841</Uniprot_ID>
      <Gene_Name>DDX17</Gene_Name>
      <EBI_ID>EBI-746012</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-746012</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9UBF1</Uniprot_ID>
      <Gene_Name>MAGEC2</Gene_Name>
      <EBI_ID>EBI-5651487</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-5651487</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13547</Uniprot_ID>
      <Gene_Name>HDAC1</Gene_Name>
      <EBI_ID>EBI-301834</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-301834</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9Y3T9</Uniprot_ID>
      <Gene_Name>NOC2L</Gene_Name>
      <EBI_ID>EBI-751547</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-751547</PPI_EBI_URL>
      <Experiment_Number>8</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P06748</Uniprot_ID>
      <Gene_Name>NPM1</Gene_Name>
      <EBI_ID>EBI-78579</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-78579</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9NPI1</Uniprot_ID>
      <Gene_Name>BRD7</Gene_Name>
      <EBI_ID>EBI-711221</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-711221</PPI_EBI_URL>
      <Experiment_Number>8</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P43356</Uniprot_ID>
      <Gene_Name>MAGEA2B</Gene_Name>
      <EBI_ID>EBI-5650739</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-5650739</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9BV47</Uniprot_ID>
      <Gene_Name>DUSP26</Gene_Name>
      <EBI_ID>EBI-2924519</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-2924519</PPI_EBI_URL>
      <Experiment_Number>9</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O75925</Uniprot_ID>
      <Gene_Name>PIAS1</Gene_Name>
      <EBI_ID>EBI-629434</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-629434</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q00987</Uniprot_ID>
      <Gene_Name>MDM2</Gene_Name>
      <EBI_ID>EBI-389668</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-389668</PPI_EBI_URL>
      <Experiment_Number>27</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P17844</Uniprot_ID>
      <Gene_Name>DDX5</Gene_Name>
      <EBI_ID>EBI-351962</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-351962</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P36873-1</Uniprot_ID>
      <Gene_Name>PPP1CC</Gene_Name>
      <EBI_ID>EBI-356289</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-356289</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P45481</Uniprot_ID>
      <Gene_Name>Crebbp</Gene_Name>
      <EBI_ID>EBI-296306</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-296306</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P29590</Uniprot_ID>
      <Gene_Name>PML</Gene_Name>
      <EBI_ID>EBI-295890</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-295890</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8WTS6</Uniprot_ID>
      <Gene_Name>SETD7</Gene_Name>
      <EBI_ID>EBI-1268586</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1268586</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q05397</Uniprot_ID>
      <Gene_Name>PTK2</Gene_Name>
      <EBI_ID>EBI-702142</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-702142</PPI_EBI_URL>
      <Experiment_Number>11</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q09472</Uniprot_ID>
      <Gene_Name>EP300</Gene_Name>
      <EBI_ID>EBI-447295</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-447295</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07817-1</Uniprot_ID>
      <Gene_Name>BCL2L1</Gene_Name>
      <EBI_ID>EBI-287195</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-287195</PPI_EBI_URL>
      <Experiment_Number>18</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P42858</Uniprot_ID>
      <Gene_Name>HTT</Gene_Name>
      <EBI_ID>EBI-466029</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-466029</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92793</Uniprot_ID>
      <Gene_Name>CREBBP</Gene_Name>
      <EBI_ID>EBI-81215</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-81215</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8N2W9</Uniprot_ID>
      <Gene_Name>PIAS4</Gene_Name>
      <EBI_ID>EBI-473160</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-473160</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q12772</Uniprot_ID>
      <Gene_Name>SREBF2</Gene_Name>
      <EBI_ID>EBI-465059</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-465059</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q96KB5</Uniprot_ID>
      <Gene_Name>PBK</Gene_Name>
      <EBI_ID>EBI-536853</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-536853</PPI_EBI_URL>
      <Experiment_Number>7</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8IZD2</Uniprot_ID>
      <Gene_Name>MLL5</Gene_Name>
      <EBI_ID>EBI-2689959</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-2689959</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q15672</Uniprot_ID>
      <Gene_Name>TWIST1</Gene_Name>
      <EBI_ID>EBI-1797287</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1797287</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P04637</Uniprot_ID>
      <Gene_Name>TP53</Gene_Name>
      <EBI_ID>EBI-617698</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-617698</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q05086</Uniprot_ID>
      <Gene_Name>UBE3A</Gene_Name>
      <EBI_ID>EBI-954357</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-954357</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P23511</Uniprot_ID>
      <Gene_Name>NFYA</Gene_Name>
      <EBI_ID>EBI-389739</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-389739</PPI_EBI_URL>
      <Experiment_Number>11</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q14191</Uniprot_ID>
      <Gene_Name>WRN</Gene_Name>
      <EBI_ID>EBI-368417</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-368417</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P10415</Uniprot_ID>
      <Gene_Name>BCL2</Gene_Name>
      <EBI_ID>EBI-77694</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-77694</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9ESJ1</Uniprot_ID>
      <Gene_Name>Cables1</Gene_Name>
      <EBI_ID>EBI-604411</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-604411</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O15169</Uniprot_ID>
      <Gene_Name>AXIN1</Gene_Name>
      <EBI_ID>EBI-710484</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-710484</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q86XK2</Uniprot_ID>
      <Gene_Name>FBXO11</Gene_Name>
      <EBI_ID>EBI-1047804</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1047804</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8IW41</Uniprot_ID>
      <Gene_Name>MAPKAPK5</Gene_Name>
      <EBI_ID>EBI-1201460</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1201460</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q96ST3</Uniprot_ID>
      <Gene_Name>SIN3A</Gene_Name>
      <EBI_ID>EBI-347218</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-347218</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P55060</Uniprot_ID>
      <Gene_Name>CSE1L</Gene_Name>
      <EBI_ID>EBI-286709</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-286709</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P12956</Uniprot_ID>
      <Gene_Name>XRCC6</Gene_Name>
      <EBI_ID>EBI-353208</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-353208</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9BX70</Uniprot_ID>
      <Gene_Name>BTBD2</Gene_Name>
      <EBI_ID>EBI-710091</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-710091</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P11473</Uniprot_ID>
      <Gene_Name>VDR</Gene_Name>
      <EBI_ID>EBI-286357</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-286357</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9BUJ2</Uniprot_ID>
      <Gene_Name>HNRNPUL1</Gene_Name>
      <EBI_ID>EBI-1018153</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1018153</PPI_EBI_URL>
      <Experiment_Number>11</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q14999</Uniprot_ID>
      <Gene_Name>CUL7</Gene_Name>
      <EBI_ID>EBI-308606</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-308606</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92993</Uniprot_ID>
      <Gene_Name>KAT5</Gene_Name>
      <EBI_ID>EBI-399080</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-399080</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P17676</Uniprot_ID>
      <Gene_Name>CEBPB</Gene_Name>
      <EBI_ID>EBI-969696</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-969696</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O88898</Uniprot_ID>
      <Gene_Name>Tp63</Gene_Name>
      <EBI_ID>EBI-2338025</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-2338025</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O60285</Uniprot_ID>
      <Gene_Name>NUAK1</Gene_Name>
      <EBI_ID>EBI-1046789</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1046789</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q93009</Uniprot_ID>
      <Gene_Name>USP7</Gene_Name>
      <EBI_ID>EBI-302474</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-302474</PPI_EBI_URL>
      <Experiment_Number>10</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q86Z02</Uniprot_ID>
      <Gene_Name>HIPK1</Gene_Name>
      <EBI_ID>EBI-692891</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-692891</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q96EB6</Uniprot_ID>
      <Gene_Name>SIRT1</Gene_Name>
      <EBI_ID>EBI-1802965</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1802965</PPI_EBI_URL>
      <Experiment_Number>13</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P06748-1</Uniprot_ID>
      <Gene_Name>NPM1</Gene_Name>
      <EBI_ID>EBI-354150</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-354150</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q13526</Uniprot_ID>
      <Gene_Name>PIN1</Gene_Name>
      <EBI_ID>EBI-714158</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-714158</PPI_EBI_URL>
      <Experiment_Number>6</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q15759</Uniprot_ID>
      <Gene_Name>MAPK11</Gene_Name>
      <EBI_ID>EBI-298304</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-298304</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P20226</Uniprot_ID>
      <Gene_Name>TBP</Gene_Name>
      <EBI_ID>EBI-355371</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-355371</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q7Z6Z7</Uniprot_ID>
      <Gene_Name>HUWE1</Gene_Name>
      <EBI_ID>EBI-625934</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-625934</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q923E4</Uniprot_ID>
      <Gene_Name>Sirt1</Gene_Name>
      <EBI_ID>EBI-1802585</EBI_ID>
      <PPI_EBI_URL>EBI-366083,EBI-1802585</PPI_EBI_URL>
      <Experiment_Number>4</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Blastoma</Disease_Name>
      <Disease_Detail>Blastoma</Disease_Detail>
      <Disease_DB>BLS003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/blastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gallbladder Adenoma</Disease_Name>
      <Disease_Detail>Gallbladder Cancer</Disease_Detail>
      <Disease_DB>GLL029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gallbladder_adenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Skin Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Skin Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>SKN022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/skin_squamous_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Peritoneal Carcinoma</Disease_Name>
      <Disease_Detail>Primary Peritoneal Carcinoma</Disease_Detail>
      <Disease_DB>PRM126</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_peritoneal_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Anaplastic Oligoastrocytoma</Disease_Name>
      <Disease_Detail>Anaplastic Oligoastrocytoma</Disease_Detail>
      <Disease_DB>ANP008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/anaplastic_oligoastrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Giant Cell Glioblastoma</Disease_Name>
      <Disease_Detail>Giant Cell Glioblastoma</Disease_Detail>
      <Disease_DB>GNT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/giant_cell_glioblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Intestinal Disease</Disease_Name>
      <Disease_Detail>Intestinal Disease</Disease_Detail>
      <Disease_DB>INT068</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intestinal_disease?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Grade Iii Astrocytoma</Disease_Name>
      <Disease_Detail>Grade Iii Astrocytoma</Disease_Detail>
      <Disease_DB>GRD007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/grade_iii_astrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Vulvar Intraepithelial Neoplasia</Disease_Name>
      <Disease_Detail>Vulvar Intraepithelial Neoplasia</Disease_Detail>
      <Disease_DB>VLV044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/vulvar_intraepithelial_neoplasia?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glioma Somatic</Disease_Name>
      <Disease_Detail>Glioma Somatic</Disease_Detail>
      <Disease_DB>GLM037</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glioma_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Nasopharynx Carcinoma</Disease_Name>
      <Disease_Detail>Nasopharynx Carcinoma</Disease_Detail>
      <Disease_DB>NSP001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nasopharynx_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Mucinous Adenocarcinoma</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_mucinous_adenocarcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Medulloblastoma</Disease_Name>
      <Disease_Detail>Medulloblastoma</Disease_Detail>
      <Disease_DB>MDL005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/medulloblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dendritic Cell Sarcoma</Disease_Name>
      <Disease_Detail>Dendritic Cell Tumor</Disease_Detail>
      <Disease_DB>DND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dendritic_cell_sarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Adenoma</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_adenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Follicular Dendritic Cell Sarcoma</Disease_Name>
      <Disease_Detail>Follicular Dendritic Cell Sarcoma</Disease_Detail>
      <Disease_DB>FLL013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/follicular_dendritic_cell_sarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pulmonary Blastoma</Disease_Name>
      <Disease_Detail>Pulmonary Blastoma</Disease_Detail>
      <Disease_DB>PLM032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pulmonary_blastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteosarcoma</Disease_Name>
      <Disease_Detail>Osteosarcoma</Disease_Detail>
      <Disease_DB>OST018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteosarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Male Germ Cell Tumor</Disease_Name>
      <Disease_Detail>Male Germ Cell Tumor</Disease_Detail>
      <Disease_DB>MLG083</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/male_germ_cell_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chronic Lymphocytic Leukemia</Disease_Name>
      <Disease_Detail>Chronic Lymphocytic Leukemia</Disease_Detail>
      <Disease_DB>CHR090</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chronic_lymphocytic_leukemia?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Cystic Teratoma</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_cystic_teratoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eccrine Porocarcinoma</Disease_Name>
      <Disease_Detail>Eccrine Porocarcinoma</Disease_Detail>
      <Disease_DB>ECC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eccrine_porocarcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thrombocythemia 1</Disease_Name>
      <Disease_Detail>Thrombocythemia</Disease_Detail>
      <Disease_DB>THR090</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thrombocythemia_1?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gemistocytic Astrocytoma</Disease_Name>
      <Disease_Detail>Gemistocytic Astrocytoma</Disease_Detail>
      <Disease_DB>GMS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gemistocytic_astrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pontocerebellar Hypoplasia</Disease_Name>
      <Disease_Detail>Pontocerebellar Hypoplasia</Disease_Detail>
      <Disease_DB>PNT019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pontocerebellar_hypoplasia?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pleomorphic Xanthoastrocytoma</Disease_Name>
      <Disease_Detail>Pleomorphic Xanthoastrocytoma</Disease_Detail>
      <Disease_DB>PLM020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pleomorphic_xanthoastrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Small Cell Carcinoma of the Bladder</Disease_Name>
      <Disease_Detail>Small Cell Carcinoma of the Bladder</Disease_Detail>
      <Disease_DB>SML031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/small_cell_carcinoma_of_the_bladder?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pituitary Carcinoma</Disease_Name>
      <Disease_Detail>Pituitary Tumors</Disease_Detail>
      <Disease_DB>PTT008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pituitary_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Serous Cystadenocarcinoma</Disease_Name>
      <Disease_Detail>Serous Cystadenocarcinoma</Disease_Detail>
      <Disease_DB>SRS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/serous_cystadenocarcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Proliferating Trichilemmal Cyst</Disease_Name>
      <Disease_Detail>Proliferating Trichilemmal Cyst</Disease_Detail>
      <Disease_DB>PRL042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/proliferating_trichilemmal_cyst?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Serous Cystadenoma</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_serous_cystadenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Chromosome 17p Deletion</Disease_Name>
      <Disease_Detail>Chromosome 17p Deletion</Disease_Detail>
      <Disease_DB>CHR208</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/chromosome_17p_deletion?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Small Cell Neuroendocrine Carcinoma</Disease_Name>
      <Disease_Detail>Small Cell Neuroendocrine Carcinoma</Disease_Detail>
      <Disease_DB>SML034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/small_cell_neuroendocrine_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Mediastinal Large B-Cell Lymphoma</Disease_Name>
      <Disease_Detail>Primary Mediastinal Large B-Cell Lymphoma</Disease_Detail>
      <Disease_DB>PRM163</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_mediastinal_large_b_cell_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hyperplastic Polyposis Syndrome</Disease_Name>
      <Disease_Detail>Hyperplastic Polyposis Syndrome</Disease_Detail>
      <Disease_DB>HYP466</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hyperplastic_polyposis_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oligoastrocytoma</Disease_Name>
      <Disease_Detail>Oligoastrocytoma</Disease_Detail>
      <Disease_DB>OLG006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oligoastrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastrointestinal Adenoma</Disease_Name>
      <Disease_Detail>Gastrointestinal Carcinoma</Disease_Detail>
      <Disease_DB>GST038</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastrointestinal_adenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Choroid Plexus Carcinoma</Disease_Name>
      <Disease_Detail>Choroid Plexus Carcinoma</Disease_Detail>
      <Disease_DB>CHR019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/choroid_plexus_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Marginal Zone B-Cell Lymphoma</Disease_Name>
      <Disease_Detail>Marginal Zone B-Cell Lymphoma</Disease_Detail>
      <Disease_DB>MRG003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/marginal_zone_b_cell_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Papilloma</Disease_Name>
      <Disease_Detail>Papilloma</Disease_Detail>
      <Disease_DB>PPL022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/papilloma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Eyelid Neoplasm</Disease_Name>
      <Disease_Detail>Eyelid Neoplasm</Disease_Detail>
      <Disease_DB>EYL001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/eyelid_neoplasm?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphoepithelioma-Like Carcinoma</Disease_Name>
      <Disease_Detail>Lymphoepithelioma-Like Carcinoma</Disease_Detail>
      <Disease_DB>LYM006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphoepithelioma_like_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tenosynovial Giant Cell Tumor</Disease_Name>
      <Disease_Detail>Tenosynovial Giant Cell Tumor</Disease_Detail>
      <Disease_DB>TNS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tenosynovial_giant_cell_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adult Astrocytic Tumour</Disease_Name>
      <Disease_Detail>Adult Astrocytic Tumour</Disease_Detail>
      <Disease_DB>ADL053</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adult_astrocytic_tumour?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Brooke-Spiegler Syndrome</Disease_Name>
      <Disease_Detail>Brooke-Spiegler Syndrome</Disease_Detail>
      <Disease_DB>BRK001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/brooke_spiegler_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pleomorphic Adenoma</Disease_Name>
      <Disease_Detail>Pleomorphic Adenoma</Disease_Detail>
      <Disease_DB>PLM014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pleomorphic_adenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Xanthogranulomatous Cholecystitis</Disease_Name>
      <Disease_Detail>Xanthogranulomatous Cholecystitis</Disease_Detail>
      <Disease_DB>XNT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/xanthogranulomatous_cholecystitis?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Xeroderma Pigmentosum</Disease_Name>
      <Disease_Detail>Xeroderma Pigmentosum</Disease_Detail>
      <Disease_DB>XRD001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/xeroderma_pigmentosum?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glioma Susceptibility 1</Disease_Name>
      <Disease_Detail>Glioma Susceptibility</Disease_Detail>
      <Disease_DB>GLM040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glioma_susceptibility_1?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neuroendocrine Carcinoma of the Cervix</Disease_Name>
      <Disease_Detail>Neuroendocrine Carcinoma of the Cervix</Disease_Detail>
      <Disease_DB>NRN006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neuroendocrine_carcinoma_of_the_cervix?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Composite Lymphoma</Disease_Name>
      <Disease_Detail>Composite Lymphoma</Disease_Detail>
      <Disease_DB>CMP001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/composite_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Multifocal Osteogenic Sarcoma</Disease_Name>
      <Disease_Detail>Multifocal Osteogenic Sarcoma</Disease_Detail>
      <Disease_DB>MLT017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multifocal_osteogenic_sarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Leukemia, Acute Lymphoblastic 3</Disease_Name>
      <Disease_Detail>Acute Lymphoblastic Leukemia</Disease_Detail>
      <Disease_DB>LKM060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/leukemia_acute_lymphoblastic_3?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pineoblastoma</Disease_Name>
      <Disease_Detail>Pineoblastoma</Disease_Detail>
      <Disease_DB>PNB001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pineoblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Sarcoma</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS061</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_sarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphangitis</Disease_Name>
      <Disease_Detail>Lymphangitis</Disease_Detail>
      <Disease_DB>LYM014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphangitis?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Embryonal Sarcoma</Disease_Name>
      <Disease_Detail>Embryonal Cancer</Disease_Detail>
      <Disease_DB>EMB007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/embryonal_sarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Epstein-Barr Virus-Associated Gastric Carcinoma</Disease_Name>
      <Disease_Detail>Epstein-Barr Virus-Associated Gastric Carcinoma</Disease_Detail>
      <Disease_DB>EPS023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/epstein_barr_virus_associated_gastric_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteoblastoma</Disease_Name>
      <Disease_Detail>Osteoblastoma</Disease_Detail>
      <Disease_DB>OST006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteoblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malignant Mixed Mullerian Tumor</Disease_Name>
      <Disease_Detail>Malignant Mixed Mullerian Tumor</Disease_Detail>
      <Disease_DB>MLG098</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malignant_mixed_mullerian_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Neuroectodermal Tumor</Disease_Name>
      <Disease_Detail>Neuroectodermal Tumor</Disease_Detail>
      <Disease_DB>NRC020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/neuroectodermal_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cerebral Primitive Neuroectodermal Tumor</Disease_Name>
      <Disease_Detail>Cerebral Primitive Neuroectodermal Tumor</Disease_Detail>
      <Disease_DB>CRB002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cerebral_primitive_neuroectodermal_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Central Neurocytoma</Disease_Name>
      <Disease_Detail>Central Neurocytoma</Disease_Detail>
      <Disease_DB>CNT019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/central_neurocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bladder Transitional Cell Carcinoma</Disease_Name>
      <Disease_Detail>Bladder Cancer</Disease_Detail>
      <Disease_DB>BLD048</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bladder_transitional_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pediatric Osteosarcoma</Disease_Name>
      <Disease_Detail>Pediatric Osteosarcoma</Disease_Detail>
      <Disease_DB>PDT021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pediatric_osteosarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Osteosarcoma, Somatic</Disease_Name>
      <Disease_Detail>Osteosarcoma</Disease_Detail>
      <Disease_DB>OST085</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/osteosarcoma_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Superficial Urinary Bladder Cancer</Disease_Name>
      <Disease_Detail>Superficial Urinary Bladder Cancer</Disease_Detail>
      <Disease_DB>SPR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/superficial_urinary_bladder_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Small Cell Carcinoma</Disease_Name>
      <Disease_Detail>Small Cell Carcinoma</Disease_Detail>
      <Disease_DB>SML001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/small_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Germ Cell Tumor</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR069</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_germ_cell_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cystic Teratoma</Disease_Name>
      <Disease_Detail>Cystic Teratoma</Disease_Detail>
      <Disease_DB>CYS017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cystic_teratoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Rift Valley Fever</Disease_Name>
      <Disease_Detail>Rift Valley Fever</Disease_Detail>
      <Disease_DB>RFT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/rift_valley_fever?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Parotid Gland Cancer</Disease_Name>
      <Disease_Detail>Parotid Gland Cancer</Disease_Detail>
      <Disease_DB>PRT009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/parotid_gland_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spitz Nevus</Disease_Name>
      <Disease_Detail>Spitz Nevus</Disease_Detail>
      <Disease_DB>SPT007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spitz_nevus?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Anal Canal Carcinoma</Disease_Name>
      <Disease_Detail>Anal Canal Carcinoma</Disease_Detail>
      <Disease_DB>ANL011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/anal_canal_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tetraploidy</Disease_Name>
      <Disease_Detail>Tetraploidy</Disease_Detail>
      <Disease_DB>TTR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tetraploidy?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Mucinous Neoplasm</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR054</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_mucinous_neoplasm?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Necrotizing Sialometaplasia</Disease_Name>
      <Disease_Detail>Necrotizing Sialometaplasia</Disease_Detail>
      <Disease_DB>NCR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/necrotizing_sialometaplasia?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Basaloid Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Basaloid Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>BSL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/basaloid_squamous_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Lymphoma</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Strongyloidiasis</Disease_Name>
      <Disease_Detail>Strongyloidiasis</Disease_Detail>
      <Disease_DB>STR008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/strongyloidiasis?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glioblastoma, Somatic</Disease_Name>
      <Disease_Detail>Glioblastoma</Disease_Detail>
      <Disease_DB>GLB008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glioblastoma_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sapho Syndrome</Disease_Name>
      <Disease_Detail>Sapho Syndrome</Disease_Detail>
      <Disease_DB>SPH001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sapho_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hypoxia</Disease_Name>
      <Disease_Detail>Hypoxia</Disease_Detail>
      <Disease_DB>HYP266</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypoxia?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Xeroderma Pigmentosum, Group C</Disease_Name>
      <Disease_Detail>Xeroderma Pigmentosum</Disease_Detail>
      <Disease_DB>XRD019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/xeroderma_pigmentosum_group_c?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malignant Fibroxanthoma</Disease_Name>
      <Disease_Detail>Malignant Fibroxanthoma</Disease_Detail>
      <Disease_DB>MLG065</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malignant_fibroxanthoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pleuropulmonary Blastoma</Disease_Name>
      <Disease_Detail>Pleuropulmonary Blastoma</Disease_Detail>
      <Disease_DB>PLR004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pleuropulmonary_blastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Villous Adenoma</Disease_Name>
      <Disease_Detail>Villous Adenoma</Disease_Detail>
      <Disease_DB>VLL006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/villous_adenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepadnavirus Infection</Disease_Name>
      <Disease_Detail>Hepadnavirus Infection</Disease_Detail>
      <Disease_DB>HPD002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepadnavirus_infection?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pinguecula</Disease_Name>
      <Disease_Detail>Pinguecula</Disease_Detail>
      <Disease_DB>PNG001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pinguecula?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreas Adenocarcinoma</Disease_Name>
      <Disease_Detail>Pancreas Adenocarcinoma</Disease_Detail>
      <Disease_DB>PNC033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreas_adenocarcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Cancer</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC035</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardia Cancer</Disease_Name>
      <Disease_Detail>Cardia Cancer</Disease_Detail>
      <Disease_DB>CRD005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardia_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Esophageal Basaloid Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Esophageal Cancer</Disease_Detail>
      <Disease_DB>ESP010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/esophageal_basaloid_squamous_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Liver Cancer</Disease_Name>
      <Disease_Detail>Liver Cancer</Disease_Detail>
      <Disease_DB>LVR011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/liver_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Primary Malignant Lymphoma</Disease_Name>
      <Disease_Detail>Primary Malignant Lymphoma</Disease_Detail>
      <Disease_DB>PRM046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/primary_malignant_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Non-Hodgkin Lymphoma</Disease_Name>
      <Disease_Detail>Non-Hodgkin Lymphoma</Disease_Detail>
      <Disease_DB>NNH001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/non_hodgkin_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Basal Cell Carcinoma 7</Disease_Name>
      <Disease_Detail>Basal Cell Carcinoma</Disease_Detail>
      <Disease_DB>BSL034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/basal_cell_carcinoma_7?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lymphoma, Non-Hodgkin, Somatic</Disease_Name>
      <Disease_Detail>Lymphoma</Disease_Detail>
      <Disease_DB>LYM060</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lymphoma_non_hodgkin_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sweat Gland Carcinoma</Disease_Name>
      <Disease_Detail>Sweat Gland Carcinoma</Disease_Detail>
      <Disease_DB>SWT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sweat_gland_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Recessive Dystrophic Epidermolysis Bullosa</Disease_Name>
      <Disease_Detail>Recessive Dystrophic Epidermolysis Bullosa</Disease_Detail>
      <Disease_DB>RCS002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/recessive_dystrophic_epidermolysis_bullosa?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Laryngeal Carcinoma</Disease_Name>
      <Disease_Detail>Laryngeal Carcinoma</Disease_Detail>
      <Disease_DB>LRY016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/laryngeal_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mutyh-Associated Polyposis</Disease_Name>
      <Disease_Detail>Mutyh-Associated Polyposis</Disease_Detail>
      <Disease_DB>MTY001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mutyh_associated_polyposis?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Uterine Corpus Cancer</Disease_Name>
      <Disease_Detail>Uterine Corpus Cancer</Disease_Detail>
      <Disease_DB>UTR033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/uterine_corpus_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Triploidy</Disease_Name>
      <Disease_Detail>Triploidy</Disease_Detail>
      <Disease_DB>TRP014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/triploidy?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gliomatosis Cerebri</Disease_Name>
      <Disease_Detail>Gliomatosis Cerebri</Disease_Detail>
      <Disease_DB>GLM004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gliomatosis_cerebri?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Giant Cell Tumor</Disease_Name>
      <Disease_Detail>Giant Cell Tumor</Disease_Detail>
      <Disease_DB>GNT008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/giant_cell_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Carcinoma in Situ</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS049</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_carcinoma_in_situ?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Porokeratosis</Disease_Name>
      <Disease_Detail>Porokeratosis</Disease_Detail>
      <Disease_DB>PRK001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/porokeratosis?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Calcifying Epithelial Odontogenic Tumor</Disease_Name>
      <Disease_Detail>Calcifying Epithelial Odontogenic Tumor</Disease_Detail>
      <Disease_DB>CLC010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/calcifying_epithelial_odontogenic_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Juvenile Pilocytic Astrocytoma</Disease_Name>
      <Disease_Detail>Juvenile Pilocytic Astrocytoma</Disease_Detail>
      <Disease_DB>JVN009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/juvenile_pilocytic_astrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Skin Papilloma</Disease_Name>
      <Disease_Detail>Skin Papilloma</Disease_Detail>
      <Disease_DB>SKN020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/skin_papilloma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Embryonal Cancer</Disease_Name>
      <Disease_Detail>Embryonal Cancer</Disease_Detail>
      <Disease_DB>EMB003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/embryonal_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Thyroid Cancer, Anaplastic</Disease_Name>
      <Disease_Detail>Thyroid Cancer</Disease_Detail>
      <Disease_DB>THY049</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/thyroid_cancer_anaplastic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Li-Fraumeni Syndrome</Disease_Name>
      <Disease_Detail>Li-Fraumeni Syndrome</Disease_Detail>
      <Disease_DB>LFR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/li_fraumeni_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mutagen Sensitivity</Disease_Name>
      <Disease_Detail>Mutagen Sensitivity</Disease_Detail>
      <Disease_DB>MTG002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mutagen_sensitivity?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hidradenocarcinoma</Disease_Name>
      <Disease_Detail>Hidradenocarcinoma</Disease_Detail>
      <Disease_DB>HDR006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hidradenocarcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adult Medulloblastoma</Disease_Name>
      <Disease_Detail>Adult Medulloblastoma</Disease_Detail>
      <Disease_DB>ADL023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adult_medulloblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Subependymal Giant Cell Astrocytoma</Disease_Name>
      <Disease_Detail>Subependymal Giant Cell Astrocytoma</Disease_Detail>
      <Disease_DB>SBP001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/subependymal_giant_cell_astrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningioma</Disease_Name>
      <Disease_Detail>Meningioma</Disease_Detail>
      <Disease_DB>MNN012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningioma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cerebellar Liponeurocytoma</Disease_Name>
      <Disease_Detail>Cerebellar Liponeurocytoma</Disease_Detail>
      <Disease_DB>CRB022</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cerebellar_liponeurocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Turcot Syndrome</Disease_Name>
      <Disease_Detail>Turcot Syndrome</Disease_Detail>
      <Disease_DB>TRC032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/turcot_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Sturge-Weber Syndrome</Disease_Name>
      <Disease_Detail>Sturge-Weber Syndrome</Disease_Detail>
      <Disease_DB>STR039</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/sturge_weber_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatic Carcinoma, Somatic</Disease_Name>
      <Disease_Detail>Pancreatic Cancer</Disease_Detail>
      <Disease_DB>PNC073</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatic_carcinoma_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cervical Cancer, Somatic</Disease_Name>
      <Disease_Detail>Cervical Cancer</Disease_Detail>
      <Disease_DB>CRV047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cervical_cancer_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Transitional Cell Carcinoma</Disease_Name>
      <Disease_Detail>Transitional Cell Carcinoma</Disease_Detail>
      <Disease_DB>TRN018</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/transitional_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glioblastoma</Disease_Name>
      <Disease_Detail>Glioblastoma</Disease_Detail>
      <Disease_DB>GLB002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glioblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Cancer</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR042</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Maxillary Sinus Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Maxillary Sinus Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>MXL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/maxillary_sinus_squamous_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Anal Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Anal Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>ANL017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/anal_squamous_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Choroid Plexus Papilloma</Disease_Name>
      <Disease_Detail>Choroid Plexus Papilloma</Disease_Detail>
      <Disease_DB>CHR029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/choroid_plexus_papilloma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatocellular Carcinoma, Somatic</Disease_Name>
      <Disease_Detail>Hepatocellular Carcinoma</Disease_Detail>
      <Disease_DB>HPT032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatocellular_carcinoma_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pseudomyxoma Peritonei</Disease_Name>
      <Disease_Detail>Pseudomyxoma Peritonei</Disease_Detail>
      <Disease_DB>PSD007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pseudomyxoma_peritonei?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Dysembryoplastic Neuroepithelial Tumor</Disease_Name>
      <Disease_Detail>Dysembryoplastic Neuroepithelial Tumor</Disease_Detail>
      <Disease_DB>DYS006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/dysembryoplastic_neuroepithelial_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Spiradenoma</Disease_Name>
      <Disease_Detail>Spiradenoma</Disease_Detail>
      <Disease_DB>SPR013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/spiradenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Natural Killer Cell Leukemia</Disease_Name>
      <Disease_Detail>Natural Killer Cell Leukemia</Disease_Detail>
      <Disease_DB>NTR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/natural_killer_cell_leukemia?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Apocrine Carcinoma</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS026</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_apocrine_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Atrophy of Prostate</Disease_Name>
      <Disease_Detail>Atrophy of Prostate</Disease_Detail>
      <Disease_DB>ATR008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/atrophy_of_prostate?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adrenocortical Carcinoma</Disease_Name>
      <Disease_Detail>Adrenocortical Carcinoma</Disease_Detail>
      <Disease_DB>ADR015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adrenocortical_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cisplatin Toxicity</Disease_Name>
      <Disease_Detail>Cisplatin Toxicity</Disease_Detail>
      <Disease_DB>CSP003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cisplatin_toxicity?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Weber Syndrome</Disease_Name>
      <Disease_Detail>Weber Syndrome</Disease_Detail>
      <Disease_DB>WBR001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/weber_syndrome?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colon Cancer, Somatic</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colon_cancer_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Female Breast Carcinoma</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>FML027</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/female_breast_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Meningothelial Meningioma</Disease_Name>
      <Disease_Detail>Meningothelial Meningioma</Disease_Detail>
      <Disease_DB>MNN004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/meningothelial_meningioma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatoblastoma, Somatic</Disease_Name>
      <Disease_Detail>Hepatoblastoma</Disease_Detail>
      <Disease_DB>HPT033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatoblastoma_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Astrocytoma</Disease_Name>
      <Disease_Detail>Astrocytoma</Disease_Detail>
      <Disease_DB>AST007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/astrocytoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer, Somatic</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer_somatic?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastrointestinal Lymphoma</Disease_Name>
      <Disease_Detail>Gastrointestinal Carcinoma</Disease_Detail>
      <Disease_DB>GST014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastrointestinal_lymphoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Barrett's Esophagus</Disease_Name>
      <Disease_Detail>Barrett's Esophagus</Disease_Detail>
      <Disease_DB>BRR003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/barretts_esophagus?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bilateral Retinoblastoma</Disease_Name>
      <Disease_Detail>Bilateral Retinoblastoma</Disease_Detail>
      <Disease_DB>BLT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bilateral_retinoblastoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Breast Cancer</Disease_Name>
      <Disease_Detail>Breast Cancer</Disease_Detail>
      <Disease_DB>BRS047</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/breast_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gliosarcoma</Disease_Name>
      <Disease_Detail>Gliosarcoma</Disease_Detail>
      <Disease_DB>GLS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gliosarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>in Situ Carcinoma</Disease_Name>
      <Disease_Detail>in Situ Carcinoma</Disease_Detail>
      <Disease_DB>INS002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/in_situ_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Hepatocellular Carcinoma, Childhood</Disease_Name>
      <Disease_Detail>Hepatocellular Carcinoma</Disease_Detail>
      <Disease_DB>HPT031</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hepatocellular_carcinoma_childhood?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Localized Osteosarcoma</Disease_Name>
      <Disease_Detail>Localized Osteosarcoma</Disease_Detail>
      <Disease_DB>LCL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/localized_osteosarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Benign Mesothelioma</Disease_Name>
      <Disease_Detail>Benign Mesothelioma</Disease_Detail>
      <Disease_DB>BNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benign_mesothelioma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Common Wart</Disease_Name>
      <Disease_Detail>Common Wart</Disease_Detail>
      <Disease_DB>CMM003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/common_wart?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colonic Adenoma Recurrence, Reduced Risk of</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN029</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colonic_adenoma_recurrence_reduced_risk_of?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pleomorphic Rhabdomyosarcoma</Disease_Name>
      <Disease_Detail>Pleomorphic Rhabdomyosarcoma</Disease_Detail>
      <Disease_DB>PLM030</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pleomorphic_rhabdomyosarcoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bile Duct Adenoma</Disease_Name>
      <Disease_Detail>Bile Duct Carcinoma</Disease_Detail>
      <Disease_DB>BLD033</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bile_duct_adenoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Papillary Glioneuronal Tumor</Disease_Name>
      <Disease_Detail>Papillary Glioneuronal Tumor</Disease_Detail>
      <Disease_DB>PPL039</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/papillary_glioneuronal_tumor?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oropharynx Cancer</Disease_Name>
      <Disease_Detail>Oropharynx Cancer</Disease_Detail>
      <Disease_DB>ORP003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oropharynx_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colonic Benign Neoplasm</Disease_Name>
      <Disease_Detail>Colon Cancer</Disease_Detail>
      <Disease_DB>CLN045</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colonic_benign_neoplasm?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Basal Cell Carcinoma</Disease_Name>
      <Disease_Detail>Basal Cell Carcinoma</Disease_Detail>
      <Disease_DB>BSL007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/basal_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Invasive Bladder Transitional Cell Carcinoma</Disease_Name>
      <Disease_Detail>Invasive Bladder Transitional Cell Carcinoma</Disease_Detail>
      <Disease_DB>INV004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/invasive_bladder_transitional_cell_carcinoma?search=TP53#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF HUMAN 53BP1 BOUND TO THE P53 TUMOR SUPRESSOR</PDB_Title>
      <PDB_ID>1GZH</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1GZH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.</PubMed_Title>
      <Author>Derbyshire DJ, et al.</Author>
      <Journal>EMBO J. 2002 Jul 15;21(14):3863-72.</Journal>
      <PubMed_ID>12110597</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR SOLUTION STRUCTURE OF THE TETRAMERIC MINIMUM TRANSFORMING DOMAIN OF P53</PDB_Title>
      <PDB_ID>1PES</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1PES</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the tetrameric minimum transforming domain of p53.</PubMed_Title>
      <Author>Lee W, et al.</Author>
      <Journal>Nat Struct Biol. 1994 Dec;1(12):877-90.</Journal>
      <PubMed_ID>7773777</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The Crystal Strucure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 364-367</PDB_Title>
      <PDB_ID>2FOJ</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2FOJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular recognition of p53 and MDM2 by USP7/HAUSP.</PubMed_Title>
      <Author>Sheng Y, et al.</Author>
      <Journal>Nat Struct Mol Biol. 2006 Mar;13(3):285-91.</Journal>
      <PubMed_ID>16474402</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis of DNA Recognition by p53 Tetramers (complex III)</PDB_Title>
      <PDB_ID>2AHI</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2AHI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of DNA recognition by p53 tetramers.</PubMed_Title>
      <Author>Kitayner M, et al.</Author>
      <Journal>Mol Cell. 2006 Jun 23;22(6):741-53.</Journal>
      <PubMed_ID>16793544</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the 53bp1 BRCT Region Complexed to Tumor Suppressor P53</PDB_Title>
      <PDB_ID>1KZY</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1KZY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.</PubMed_Title>
      <Author>Joo WS, et al.</Author>
      <Journal>Genes Dev. 2002 Mar 1;16(5):583-93.</Journal>
      <PubMed_ID>11877378</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 Core Domain Mutant V157F</PDB_Title>
      <PDB_ID>2QXA</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2QXA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of oncogenic, suppressor and rescued p53 core domain mutants and the rescue mechanism of global suppressor mutations</PubMed_Title>
      <Author>Luecke H, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>P53-53BP2 COMPLEX</PDB_Title>
      <PDB_ID>1YCS</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1YCS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.</PubMed_Title>
      <Author>Gorina S, et al.</Author>
      <Journal>Science. 1996 Nov 8;274(5289):1001-5.</Journal>
      <PubMed_ID>8875926</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain with hot spot mutation R249S and second site suppressor mutation H168R in sequence-specific complex with DNA</PDB_Title>
      <PDB_ID>3D0A</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=3D0A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</PubMed_Title>
      <Author>Suad O, et al.</Author>
      <Journal>J Mol Biol. 2009 Jan 9;385(1):249-65.</Journal>
      <PubMed_ID>18996393</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT T123A-M133L-H168R-V203A-N239Y-R249S-N268D</PDB_Title>
      <PDB_ID>2BIQ</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2BIQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>J Biol Chem. 2005 Apr 22;280(16):16030-7.</Journal>
      <PubMed_ID>15703170</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-R249S-N268D</PDB_Title>
      <PDB_ID>2BIP</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2BIP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>J Biol Chem. 2005 Apr 22;280(16):16030-7.</Journal>
      <PubMed_ID>15703170</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-G245S-N268D</PDB_Title>
      <PDB_ID>2J1Y</PDB_ID>
      <Resolution>1.69</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J1Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61.</Journal>
      <PubMed_ID>17015838</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-F270L</PDB_Title>
      <PDB_ID>2J1Z</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J1Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61.</Journal>
      <PubMed_ID>17015838</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Sir2-p53 peptide-nicotinamide</PDB_Title>
      <PDB_ID>1YC5</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1YC5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>NICOTINAMIDE</Ligand_Name>
      <PubMed_Title>Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.</PubMed_Title>
      <Author>Avalos JL, et al.</Author>
      <Journal>Mol Cell. 2005 Mar 18;17(6):855-68.</Journal>
      <PubMed_ID>15780941</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-N268D</PDB_Title>
      <PDB_ID>2BIN</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2BIN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>J Biol Chem. 2005 Apr 22;280(16):16030-7.</Journal>
      <PubMed_ID>15703170</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of p53DBD(R282Q) at 1.54-angstrom Resolution</PDB_Title>
      <PDB_ID>2PCX</PDB_ID>
      <Resolution>1.54</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2PCX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Impact of low-frequency hotspot mutation R282Q on the structure of p53 DNA-binding domain as revealed by crystallography at 1.54 angstroms resolution.</PubMed_Title>
      <Author>Tu C, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr. 2008 May;64(Pt 5):471-7.</Journal>
      <PubMed_ID>18453682</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273H</PDB_Title>
      <PDB_ID>2BIM</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2BIM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>J Biol Chem. 2005 Apr 22;280(16):16030-7.</Journal>
      <PubMed_ID>15703170</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis of DNA Recognition by p53 Tetramers (complex II)</PDB_Title>
      <PDB_ID>2ATA</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2ATA</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of DNA recognition by p53 tetramers.</PubMed_Title>
      <Author>Kitayner M, et al.</Author>
      <Journal>Mol Cell. 2006 Jun 23;22(6):741-53.</Journal>
      <PubMed_ID>16793544</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES)</PDB_Title>
      <PDB_ID>3SAK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3SAK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Improving the Packing and Accuracy of NMR Structure with a Pseudopotential for the Radius of Gyration</PubMed_Title>
      <Author>Kuszewski J, et al.</Author>
      <Journal>(1999) J.Am.Chem.Soc. 121: 2337-2338</Journal>
      <PubMed_ID>Not in PubMed</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain with hot spot mutation R249S (II)</PDB_Title>
      <PDB_ID>3D05</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3D05</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</PubMed_Title>
      <Author>Suad O, et al.</Author>
      <Journal>J Mol Biol. 2009 Jan 9;385(1):249-65.</Journal>
      <PubMed_ID>18996393</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES)</PDB_Title>
      <PDB_ID>1SAK</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1SAK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined solution structure of the oligomerization domain of the tumour suppressor p53.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Nat Struct Biol. 1995 Apr;2(4):321-33.</Journal>
      <PubMed_ID>7796267</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>p53N (fragment 33-60) bound to RPA70N</PDB_Title>
      <PDB_ID>2B3G</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2B3G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A.</PubMed_Title>
      <Author>Bochkareva E, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15412-7.</Journal>
      <PubMed_ID>16234232</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA</PDB_Title>
      <PDB_ID>1TUP</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1TUP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.</PubMed_Title>
      <Author>Cho Y, et al.</Author>
      <Journal>Science. 1994 Jul 15;265(5170):346-55.</Journal>
      <PubMed_ID>8023157</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL-MOLECULE DRUG PHIKAN083</PDB_Title>
      <PDB_ID>2VUK</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2VUK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine</Ligand_Name>
      <PubMed_Title>Targeted rescue of a destabilized mutant of p53 by an in silico screened drug.</PubMed_Title>
      <Author>Boeckler FM, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10360-5.</Journal>
      <PubMed_ID>18650397</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES)</PDB_Title>
      <PDB_ID>1SAJ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=1SAJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined solution structure of the oligomerization domain of the tumour suppressor p53.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Nat Struct Biol. 1995 Apr;2(4):321-33.</Journal>
      <PubMed_ID>7796267</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES)</PDB_Title>
      <PDB_ID>1SAH</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1SAH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined solution structure of the oligomerization domain of the tumour suppressor p53.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Nat Struct Biol. 1995 Apr;2(4):321-33.</Journal>
      <PubMed_ID>7796267</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain</PDB_Title>
      <PDB_ID>3DAC</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=3DAC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.</PubMed_Title>
      <Author>Popowicz GM, et al.</Author>
      <Journal>Cell Cycle. 2008 Aug;7(15):2441-3.</Journal>
      <PubMed_ID>18677113</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 Core Domain Mutant V157F/N235K/N239Y</PDB_Title>
      <PDB_ID>2QVQ</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2QVQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of oncogenic, suppressor and rescued p53 core domain mutants and the rescue mechanism of global suppressor mutations</PubMed_Title>
      <Author>Wang Y, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the TRAF-like domain of HAUSP/USP7 bound to a p53 peptide</PDB_Title>
      <PDB_ID>2F1X</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2F1X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.</PubMed_Title>
      <Author>Hu M, et al.</Author>
      <Journal>PLoS Biol. 2006 Feb;4(2):e27.</Journal>
      <PubMed_ID>16402859</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of a ternary complex of the methyltransferase SET9 (also known as SET7/9) with a P53 peptide and SAH</PDB_Title>
      <PDB_ID>1XQH</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1XQH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>S-ADENOSYL-L-HOMOCYSTEINE</Ligand_Name>
      <PubMed_Title>Regulation of p53 activity through lysine methylation.</PubMed_Title>
      <Author>Chuikov S, et al.</Author>
      <Journal>Nature. 2004 Nov 18;432(7015):353-60.</Journal>
      <PubMed_ID>15525938</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 4-(TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE</PDB_Title>
      <PDB_ID>2X0V</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2X0V</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>4-(TRIFLUOROMETHYL)BENZENE-1,2-DIAMINE</Ligand_Name>
      <PubMed_Title>Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.</PubMed_Title>
      <Author>Basse N, et al.</Author>
      <Journal>Chem Biol. 2010 Jan 29;17(1):46-56.</Journal>
      <PubMed_ID>20142040</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain in the absence of DNA</PDB_Title>
      <PDB_ID>2OCJ</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2OCJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the human p53 core domain in the absence of DNA.</PubMed_Title>
      <Author>Wang Y, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):276-81.</Journal>
      <PubMed_ID>17327663</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P53 CORE DOMAIN IN COMPLEX WITH DNA</PDB_Title>
      <PDB_ID>1TSR</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1TSR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.</PubMed_Title>
      <Author>Cho Y, et al.</Author>
      <Journal>Science. 1994 Jul 15;265(5170):346-55.</Journal>
      <PubMed_ID>8023157</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF P53 TETRAMERIZATION DOMAIN</PDB_Title>
      <PDB_ID>1C26</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1C26</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.</PubMed_Title>
      <Author>Jeffrey PD, et al.</Author>
      <Journal>Science. 1995 Mar 10;267(5203):1498-502.</Journal>
      <PubMed_ID>7878469</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain with hot spot mutation R249S (I)</PDB_Title>
      <PDB_ID>3D06</PDB_ID>
      <Resolution>1.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=3D06</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</PubMed_Title>
      <Author>Suad O, et al.</Author>
      <Journal>J Mol Biol. 2009 Jan 9;385(1):249-65.</Journal>
      <PubMed_ID>18996393</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis of DNA Recognition by p53 Tetramers (complex IV)</PDB_Title>
      <PDB_ID>2ADY</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2ADY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of DNA recognition by p53 tetramers.</PubMed_Title>
      <Author>Kitayner M, et al.</Author>
      <Journal>Mol Cell. 2006 Jun 23;22(6):741-53.</Journal>
      <PubMed_ID>16793544</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO 5,6-DIMETHOXY-2-METHYLBENZOTHIAZOLE</PDB_Title>
      <PDB_ID>2X0W</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2X0W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>5,6-DIMETHOXY-2-METHYL-1,3-BENZOTHIAZOLE</Ligand_Name>
      <PubMed_Title>Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.</PubMed_Title>
      <Author>Basse N, et al.</Author>
      <Journal>Chem Biol. 2010 Jan 29;17(1):46-56.</Journal>
      <PubMed_ID>20142040</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE HUMAN P53 CORE DOMAIN MUTANT M133L/V203A/N239Y/N268D AT 1.9 A RESOLUTION.</PDB_Title>
      <PDB_ID>1UOL</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1UOL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a superstable mutant of human p53 core domain. Insights into the mechanism of rescuing oncogenic mutations.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>J Biol Chem. 2004 Jan 9;279(2):1291-6.</Journal>
      <PubMed_ID>14534297</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR SOLUTION STRUCTURE OF DESIGNED P53 DIMER</PDB_Title>
      <PDB_ID>1HS5</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1HS5</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and functionality of a designed p53 dimer.</PubMed_Title>
      <Author>Davison TS, et al.</Author>
      <Journal>J Mol Biol. 2001 Mar 23;307(2):605-17.</Journal>
      <PubMed_ID>11254385</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain with hot spot mutation R249S and second-site suppressor mutation H168R</PDB_Title>
      <PDB_ID>3D08</PDB_ID>
      <Resolution>1.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=3D08</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</PubMed_Title>
      <Author>Suad O, et al.</Author>
      <Journal>J Mol Biol. 2009 Jan 9;385(1):249-65.</Journal>
      <PubMed_ID>18996393</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273C</PDB_Title>
      <PDB_ID>2J20</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J20</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61.</Journal>
      <PubMed_ID>17015838</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION SOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR</PDB_Title>
      <PDB_ID>1OLG</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1OLG</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Science. 1994 Jul 15;265(5170):386-91.</Journal>
      <PubMed_ID>8023159</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of human p53 DNA binding domain.</PDB_Title>
      <PDB_ID>2FEJ</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2FEJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of p53 core domain: structural basis for its instability.</PubMed_Title>
      <Author>Canadillas JM, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2109-14.</Journal>
      <PubMed_ID>16461916</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P53 TETRAMERIZATION DOMAIN MUTANT Y327S T329G Q331G</PDB_Title>
      <PDB_ID>2J11</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J11</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.</PubMed_Title>
      <Author>Mora P, et al.</Author>
      <Journal>Proteins. 2008 Jun;71(4):1670-85.</Journal>
      <PubMed_ID>18076077</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis for the Regulation of p53 Function by p300</PDB_Title>
      <PDB_ID>2K8F</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2K8F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.</PubMed_Title>
      <Author>Feng H, et al.</Author>
      <Journal>Structure. 2009 Feb 13;17(2):202-10.</Journal>
      <PubMed_ID>19217391</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P53 TETRAMERIZATION DOMAIN MUTANT T329F Q331K</PDB_Title>
      <PDB_ID>2J10</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J10</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.</PubMed_Title>
      <Author>Mora P, et al.</Author>
      <Journal>Proteins. 2008 Jun;71(4):1670-85.</Journal>
      <PubMed_ID>18076077</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES)</PDB_Title>
      <PDB_ID>1SAL</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=1SAL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined solution structure of the oligomerization domain of the tumour suppressor p53.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Nat Struct Biol. 1995 Apr;2(4):321-33.</Journal>
      <PubMed_ID>7796267</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P53 TETRAMERIZATION DOMAIN CRYSTAL STRUCTURE</PDB_Title>
      <PDB_ID>1AIE</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1AIE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallization and structure solution of p53 (residues 326-356) by molecular replacement using an NMR model as template.</PubMed_Title>
      <Author>Mittl PR, et al.</Author>
      <Journal>Acta Crystallogr D Biol Crystallogr. 1998 Jan 1;54(Pt 1):86-9.</Journal>
      <PubMed_ID>9761820</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF P53</PDB_Title>
      <PDB_ID>1YCR</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1YCR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.</PubMed_Title>
      <Author>Kussie PH, et al.</Author>
      <Journal>Science. 1996 Nov 8;274(5289):948-53.</Journal>
      <PubMed_ID>8875929</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of a Sir2 enzyme bound to an acetylated p53 peptide</PDB_Title>
      <PDB_ID>1MA3</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1MA3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2-(N-MORPHOLINO)-ETHANESULFONIC ACID</Ligand_Name>
      <PubMed_Title>Structure of a Sir2 enzyme bound to an acetylated p53 peptide.</PubMed_Title>
      <Author>Avalos JL, et al.</Author>
      <Journal>Mol Cell. 2002 Sep;10(3):523-35.</Journal>
      <PubMed_ID>12408821</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The Crystal Strucure of the N-terminal domain of HAUSP/USP7 complexed with p53 peptide 359-362</PDB_Title>
      <PDB_ID>2FOO</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2FOO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular recognition of p53 and MDM2 by USP7/HAUSP.</PubMed_Title>
      <Author>Sheng Y, et al.</Author>
      <Journal>Nat Struct Mol Biol. 2006 Mar;13(3):285-91.</Journal>
      <PubMed_ID>16474402</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF THE C-TERMINAL NEGATIVE REGULATORY DOMAIN OF P53 IN A COMPLEX WITH CA2+-BOUND S100B(BB)</PDB_Title>
      <PDB_ID>1DT7</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1DT7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the negative regulatory domain of p53 bound to S100B(betabeta).</PubMed_Title>
      <Author>Rustandi RR, et al.</Author>
      <Journal>Nat Struct Biol. 2000 Jul;7(7):570-4.</Journal>
      <PubMed_ID>10876243</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I-N268D</PDB_Title>
      <PDB_ID>2WGX</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2WGX</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Stabilising the DNA-binding domain of p53 by rational design of its hydrophobic core.</PubMed_Title>
      <Author>Khoo KH, et al.</Author>
      <Journal>Protein Eng Des Sel. 2009 Jul;22(7):421-30.</Journal>
      <PubMed_ID>19515728</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR Structure of CBP Bromodomain in complex with p53 peptide</PDB_Title>
      <PDB_ID>1JSP</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1JSP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N(6)-ACETYLLYSINE</Ligand_Name>
      <PubMed_Title>Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.</PubMed_Title>
      <Author>Mujtaba S, et al.</Author>
      <Journal>Mol Cell. 2004 Jan 30;13(2):251-63.</Journal>
      <PubMed_ID>14759370</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W</PDB_Title>
      <PDB_ID>2J21</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J21</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61.</Journal>
      <PubMed_ID>17015838</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the activation domain of p53</PDB_Title>
      <PDB_ID>2GS0</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2GS0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the Tfb1/p53 complex: Insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53.</PubMed_Title>
      <Author>Di Lello P, et al.</Author>
      <Journal>Mol Cell. 2006 Jun 23;22(6):731-40.</Journal>
      <PubMed_ID>16793543</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The Structure of the Oncoprotein SV40 Large T Antigen and p53 Tumor Suppressor Complex</PDB_Title>
      <PDB_ID>2H1L</PDB_ID>
      <Resolution>3.16</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2H1L</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.</PubMed_Title>
      <Author>Lilyestrom W, et al.</Author>
      <Journal>Genes Dev. 2006 Sep 1;20(17):2373-82.</Journal>
      <PubMed_ID>16951253</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>P53 TETRAMERIZATION DOMAIN WILD TYPE</PDB_Title>
      <PDB_ID>2J0Z</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J0Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solvent-exposed residues located in the beta-sheet modulate the stability of the tetramerization domain of p53--a structural and combinatorial approach.</PubMed_Title>
      <Author>Mora P, et al.</Author>
      <Journal>Proteins. 2008 Jun;71(4):1670-85.</Journal>
      <PubMed_ID>18076077</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE DETERMINATION OF A P53 MUTANT DIMERIZATION DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE</PDB_Title>
      <PDB_ID>1A1U</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1A1U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Hydrophobic side-chain size is a determinant of the three-dimensional structure of the p53 oligomerization domain.</PubMed_Title>
      <Author>McCoy M, et al.</Author>
      <Journal>EMBO J. 1997 Oct 15;16(20):6230-6.</Journal>
      <PubMed_ID>9321402</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO A 2-AMINO SUBSTITUTED BENZOTHIAZOLE SCAFFOLD</PDB_Title>
      <PDB_ID>2X0U</PDB_ID>
      <Resolution>1.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2X0U</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>6,7-DIHYDRO[1,4]DIOXINO[2,3-F][1,3]BENZOTHIAZOL- 2-AMINE</Ligand_Name>
      <PubMed_Title>Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.</PubMed_Title>
      <Author>Basse N, et al.</Author>
      <Journal>Chem Biol. 2010 Jan 29;17(1):46-56.</Journal>
      <PubMed_ID>20142040</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH-RESOLUTION SOLUTION STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR</PDB_Title>
      <PDB_ID>1OLH</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1OLH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>High-resolution structure of the oligomerization domain of p53 by multidimensional NMR.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Science. 1994 Jul 15;265(5170):386-91.</Journal>
      <PubMed_ID>8023159</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>NMR SOLUTION STRUCTURE OF THE TETRAMERIC MINIMUM TRANSFORMING DOMAIN OF P53</PDB_Title>
      <PDB_ID>1PET</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1PET</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the tetrameric minimum transforming domain of p53.</PubMed_Title>
      <Author>Lee W, et al.</Author>
      <Journal>Nat Struct Biol. 1994 Dec;1(12):877-90.</Journal>
      <PubMed_ID>7773777</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain</PDB_Title>
      <PDB_ID>3DAB</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3DAB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.</PubMed_Title>
      <Author>Popowicz GM, et al.</Author>
      <Journal>Cell Cycle. 2008 Aug;7(15):2441-3.</Journal>
      <PubMed_ID>18677113</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAC STRUCTURES)</PDB_Title>
      <PDB_ID>1SAE</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1SAE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined solution structure of the oligomerization domain of the tumour suppressor p53.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Nat Struct Biol. 1995 Apr;2(4):321-33.</Journal>
      <PubMed_ID>7796267</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HIGH RESOLUTION SOLUTION NMR STRUCTURE OF THE OLIGOMERIZATION DOMAIN OF P53 BY MULTI-DIMENSIONAL NMR (SAD STRUCTURES)</PDB_Title>
      <PDB_ID>1SAF</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1SAF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Refined solution structure of the oligomerization domain of the tumour suppressor p53.</PubMed_Title>
      <Author>Clore GM, et al.</Author>
      <Journal>Nat Struct Biol. 1995 Apr;2(4):321-33.</Journal>
      <PubMed_ID>7796267</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis of DNA Recognition by p53 Tetramers (complex I)</PDB_Title>
      <PDB_ID>2AC0</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2AC0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of DNA recognition by p53 tetramers.</PubMed_Title>
      <Author>Kitayner M, et al.</Author>
      <Journal>Mol Cell. 2006 Jun 23;22(6):741-53.</Journal>
      <PubMed_ID>16793544</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 Core Domain Mutant N239Y</PDB_Title>
      <PDB_ID>2QXC</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2QXC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of oncogenic, suppressor and rescued p53 core domain mutants and the rescue mechanism of global suppressor mutations</PubMed_Title>
      <Author>Luecke H, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 Core Domain Mutant N235K</PDB_Title>
      <PDB_ID>2QXB</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=2QXB</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structures of oncogenic, suppressor and rescued p53 core domain mutants and the rescue mechanism of global suppressor mutations</PubMed_Title>
      <Author>Luecke H, et al.</Author>
      <Journal>To be Published</Journal>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D</PDB_Title>
      <PDB_ID>2J1W</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J1W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61.</Journal>
      <PubMed_ID>17015838</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer</PDB_Title>
      <PDB_ID>3KMD</PDB_ID>
      <Resolution>2.15</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3KMD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.</PubMed_Title>
      <Author>Chen Y, et al.</Author>
      <Journal>Structure. 2010 Feb 10;18(2):246-56.</Journal>
      <PubMed_ID>20159469</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y220C-N239Y-N268D</PDB_Title>
      <PDB_ID>2J1X</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2J1X</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.</PubMed_Title>
      <Author>Joerger AC, et al.</Author>
      <Journal>Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61.</Journal>
      <PubMed_ID>17015838</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53</PDB_Title>
      <PDB_ID>1H26</PDB_ID>
      <Resolution>2.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1H26</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PHOSPHOTHREONINE</Ligand_Name>
      <PubMed_Title>Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.</PubMed_Title>
      <Author>Lowe ED, et al.</Author>
      <Journal>Biochemistry. 2002 Dec 31;41(52):15625-34.</Journal>
      <PubMed_ID>12501191</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain with hot spot mutation R249S and second-site suppressor mutations H168R and T123A</PDB_Title>
      <PDB_ID>3D09</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=3D09</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</PubMed_Title>
      <Author>Suad O, et al.</Author>
      <Journal>J Mol Biol. 2009 Jan 9;385(1):249-65.</Journal>
      <PubMed_ID>18996393</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human p53 core domain with hot spot mutation R249S (III)</PDB_Title>
      <PDB_ID>3D07</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore.do?structureId=3D07</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.</PubMed_Title>
      <Author>Suad O, et al.</Author>
      <Journal>J Mol Biol. 2009 Jan 9;385(1):249-65.</Journal>
      <PubMed_ID>18996393</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05222</Pathway_ID>
      <Pathway_Title>Small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05213</Pathway_ID>
      <Pathway_Title>Endometrial cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05220</Pathway_ID>
      <Pathway_Title>Chronic myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05215</Pathway_ID>
      <Pathway_Title>Prostate cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05169</Pathway_ID>
      <Pathway_Title>Epstein-Barr virus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05213</Pathway_ID>
      <Pathway_Title>Endometrial cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04919</Pathway_ID>
      <Pathway_Title>Thyroid hormone signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04310</Pathway_ID>
      <Pathway_Title>Wnt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04919</Pathway_ID>
      <Pathway_Title>Thyroid hormone signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05161</Pathway_ID>
      <Pathway_Title>Hepatitis B</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05014</Pathway_ID>
      <Pathway_Title>Amyotrophic lateral sclerosis (ALS)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05202</Pathway_ID>
      <Pathway_Title>Transcriptional misregulation in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04210</Pathway_ID>
      <Pathway_Title>Apoptosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05210</Pathway_ID>
      <Pathway_Title>Colorectal cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04151</Pathway_ID>
      <Pathway_Title>PI3K-Akt signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04115</Pathway_ID>
      <Pathway_Title>p53 signaling pathway</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05220</Pathway_ID>
      <Pathway_Title>Chronic myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05212</Pathway_ID>
      <Pathway_Title>Pancreatic cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05166</Pathway_ID>
      <Pathway_Title>HTLV-I infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05162</Pathway_ID>
      <Pathway_Title>Measles</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05216</Pathway_ID>
      <Pathway_Title>Thyroid cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04110</Pathway_ID>
      <Pathway_Title>Cell cycle</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05230</Pathway_ID>
      <Pathway_Title>Central carbon metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05218</Pathway_ID>
      <Pathway_Title>Melanoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05230</Pathway_ID>
      <Pathway_Title>Central carbon metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05219</Pathway_ID>
      <Pathway_Title>Bladder cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04010</Pathway_ID>
      <Pathway_Title>MAPK signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05217</Pathway_ID>
      <Pathway_Title>Basal cell carcinoma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05214</Pathway_ID>
      <Pathway_Title>Glioma</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05223</Pathway_ID>
      <Pathway_Title>Non-small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05230</Pathway_ID>
      <Pathway_Title>Central carbon metabolism in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05220</Pathway_ID>
      <Pathway_Title>Chronic myeloid leukemia</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05016</Pathway_ID>
      <Pathway_Title>Huntington's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05205</Pathway_ID>
      <Pathway_Title>Proteoglycans in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05161</Pathway_ID>
      <Pathway_Title>Hepatitis B</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.c.f.b.b.html</SCOP_URL>
    <CATH_Class>Mainly beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1tup</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>range,106,113;range,146,156</Site_Detail>
      <Site_Reference>Ravera MW, et al. Oncogene. 1998,16(15):1993-1999.</Site_Reference>
      <Site_Type>Antibody-induced</Site_Type>
      <PubMed_ID>9591783</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD02120001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02120018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>